| Tova Erreich, MA, CCC-SLP | |
|
220 High St, Passaic, NJ 07055-4623 | |
| (973) 493-2538 | |
| Not Available |
| Full Name | Tova Erreich |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 220 High St, Passaic, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124460167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00589000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tova Erreich, MA, CCC-SLP 220 High St, Passaic, NJ 07055-4623 Ph: (973) 493-2538 | Tova Erreich, MA, CCC-SLP 220 High St, Passaic, NJ 07055-4623 Ph: (973) 493-2538 |
News Archive
When we are faced with a decision, and we're not sure what to do, usually we'll just go with the majority opinion.
Three-dimensional image simulation is popular among women planning breast augmentation surgery.But while this evolving technology may enhance communication, it doesn't improve patient satisfaction with the results of the procedure, reports a paper in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Dr Shigeru Omi, World Health Organization Regional Director for the Western Pacific, has warned of the danger of HIV "bridging" into the general population from infected individuals with high-risk behaviour unless countries and areas in the Region act now to avoid a major HIV/AIDS epidemic.
Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has increased and subsequently closed the non-brokered private placement previously announced on August 19, 2009.
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.
› Verified 8 days ago
Judith Elk, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 92 Van Houten Ave, Passaic, NJ 07055 Phone: 973-558-0964 | |
Annie Rosen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 199 Howard Ave, Passaic, NJ 07055 Phone: 201-777-0473 | |
Mrs. Rebecca Brisman, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Ridge Ave, Passaic, NJ 07055 Phone: 973-393-4528 | |
Elisheva Lax, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Barry Pl, Passaic, NJ 07055 Phone: 201-317-5673 | |
Mrs. Danielle Robyn Kramer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 Passaic Ave, 1f, Passaic, NJ 07055 Phone: 201-658-8847 | |
Mrs. Hadassah Silverberg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 331 Pennington Ave, Passaic, NJ 07055 Phone: 443-418-2274 |